Tag Archive for: Revance Therapeutics

Botox sales, especially for aesthetic use, have been under pressure over the last few quarters due to economic uncertainties. Investors have also been concerned about potential market share losses to new entrants.

The U.S. Food and Drug Administrationon Thursday approved Revance Therapeutics’ anti-wrinkle injection, setting up a challenger for market leader AbbVie’s Botox that has long dominated the aesthetic market.